File Download
Patent History
- ApplicationUS 12/913395 2010-10-27
- PublicationUS 20110098264 2011-04-28
Patent Family
Supplementary
-
Citations:
- Appears in Collections:
Patent: PHARMACEUTICAL COMPOSITION CONTAINING CYCLOMETALATED N-HETEROCYCLIC CARBENE COMPLEXES FOR CANCER TREATMENT
Title | PHARMACEUTICAL COMPOSITION CONTAINING CYCLOMETALATED N-HETEROCYCLIC CARBENE COMPLEXES FOR CANCER TREATMENT |
---|---|
Priority Date | 2010-10-27 US 12/913395 2009-10-28 US 12/255667P 2010-02-05 US 12/301752P |
Inventors | |
Issue Date | 2011 |
Citation | US Published patent application US 20110098264. Washington, DC: US Patent and Trademark Office (USPTO), 2011 How to Cite? |
Abstract | The present disclosure is related to a pharmaceutical composition for treatment of cancer comprising a cyclometalated N-heterocyclic carbene complex. The cyclometalated N-heterocyclic carbene complex contains a gold(III) or a platinum(II) atom. The pharmaceutical composition possesses anti-cancer activity such as the induction of cell death, inhibition of cellular proliferation, inhibition of topoisomerase and/or poisoning of topoisomerase. |
Persistent Identifier | http://hdl.handle.net/10722/206622 |
References |
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2014-11-21T08:07:26Z | - |
dc.date.available | 2014-11-21T08:07:26Z | - |
dc.date.issued | 2011 | en_US |
dc.identifier.citation | US Published patent application US 20110098264. Washington, DC: US Patent and Trademark Office (USPTO), 2011 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/206622 | - |
dc.description.abstract | The present disclosure is related to a pharmaceutical composition for treatment of cancer comprising a cyclometalated N-heterocyclic carbene complex. The cyclometalated N-heterocyclic carbene complex contains a gold(III) or a platinum(II) atom. The pharmaceutical composition possesses anti-cancer activity such as the induction of cell death, inhibition of cellular proliferation, inhibition of topoisomerase and/or poisoning of topoisomerase. | en_US |
dc.title | PHARMACEUTICAL COMPOSITION CONTAINING CYCLOMETALATED N-HETEROCYCLIC CARBENE COMPLEXES FOR CANCER TREATMENT | en_US |
dc.type | Patent | en_US |
dc.identifier.authority | CHE, CHI MING=rp00670 | en_US |
dc.description.nature | published_or_final_version | en_US |
dc.contributor.inventor | CHE, CHI MING | en_US |
dc.contributor.inventor | SUN, RAYMOND WAI-YIN | en_US |
dc.contributor.inventor | CHOW, LOK FUNG | en_US |
dc.contributor.inventor | YAN, JING | en_US |
patents.identifier.application | US 12/913395 | en_US |
patents.description.assignee | UNIV HONG KONG [HK] | en_US |
patents.description.country | United States of America | en_US |
patents.date.publication | 2011-04-28 | en_US |
dc.relation.references | US 2009110750 (A1) 2009-04-30 | en_US |
patents.identifier.hkutechid | Chm-2009-00331-1 | en_US |
patents.date.application | 2010-10-27 | en_US |
patents.date.priority | 2010-10-27 US 12/913395 | en_US |
patents.date.priority | 2009-10-28 US 12/255667P | en_US |
patents.date.priority | 2010-02-05 US 12/301752P | en_US |
patents.description.cc | us | en_US |
patents.identifier.publication | US 20110098264 | en_US |
patents.relation.family | U S8530659 (B2) 2013-09-10 | en_US |
patents.relation.family | CN 102741262 (A) 2012-10-17 | en_US |
patents.relation.family | EP 2493896 (A1) 2012-09-05 | en_US |
patents.relation.family | US 2013324511 (A1) 2013-12-05 | en_US |
patents.relation.family | WO 2011050574 (A1) 2011-05-05 | en_US |
patents.description.kind | A1 | en_US |